Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group study
Open Access
- 1 October 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (10) , 1175-1179
- https://doi.org/10.1023/a:1008372529239
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Mature results from three large controlled studies with raltitrexed ('Tomudex')British Journal of Cancer, 1998
- Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.Journal of Clinical Oncology, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A multicenter phase II studyCancer, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Human tumor cloning assays: Applications in clinical oncology and new antineoplastic agent developmentCancer and Metastasis Reviews, 1988